EDGAR Filing Documents for 0001193125-17-088280

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-17-088280

Filing Date

2017-03-20

Accepted

2017-03-20 08:07:11

Documents

Effectiveness Date

2017-03-20

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d349376d8k.htm	DEFA14A	64384
2	EX-2.1	d349376dex21.htm	EX-2.1	510112
3	EX-2.2	d349376dex22.htm	EX-2.2	188787
4	EX-2.3	d349376dex23.htm	EX-2.3	185280
5	EX-3.1	d349376dex31.htm	EX-3.1	3103
6	EX-10.1	d349376dex101.htm	EX-10.1	98702
7	EX-10.2	d349376dex102.htm	EX-10.2	71634
8	EX-10.3	d349376dex103.htm	EX-10.3	30978
9	EX-10.4	d349376dex104.htm	EX-10.4	43572
10	EX-10.5	d349376dex105.htm	EX-10.5	42133
11	EX-10.6	d349376dex106.htm	EX-10.6	42220
12	EX-99.1	d349376dex991.htm	EX-99.1	17777
13	GRAPHIC	g349376exglogo.jpg	GRAPHIC	9227
14	GRAPHIC	g349376g0319224559489.jpg	GRAPHIC	3200
15	GRAPHIC	g349376g0319224600705.jpg	GRAPHIC	3265
16	GRAPHIC	g349376g0319224600752.jpg	GRAPHIC	3265
17	GRAPHIC	g349376logo.jpg	GRAPHIC	9227
	Complete submission text file	0001193125-17-088280.txt		1339340

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451

Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300

Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)